Synonyms: D5v8 | Herceptin® | R-597
trastuzumab is an approved drug (FDA (1998), EMA (2000))
Compound class:
Antibody
Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Biosimilars:
View more information in the IUPHAR Pharmacology Education Project: trastuzumab |
Classification | |
Compound class | Antibody |
Approved drug? | Yes (FDA (1998), EMA (2000)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names | |
INN number | INN |
7637 | trastuzumab |
Synonyms |
D5v8 | Herceptin® | R-597 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 97 |
Reactome Drug | R-ALL-9634466 |
Reactome Reaction | R-HSA-9665405, R-HSA-9649393, R-HSA-9652277, R-HSA-9665232, R-HSA-9665696 |
Other databases | |
GtoPdb PubChem SID | 178101775 |
PubChem SID | 178101775 |
Search PubMed clinical trials | trastuzumab |
Search PubMed titles | trastuzumab |
Search PubMed titles/abstracts | trastuzumab |
Wikipedia | Trastuzumab |